[Federal Register Volume 80, Number 225 (Monday, November 23, 2015)]
[Notices]
[Page 72954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-29778]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE ARMY


Intent To Grant an Exclusive License of U.S. Government-Owned 
Patents

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 
(a)(1)(i), announcement is made of the intent to grant an exclusive, 
royalty-bearing, revocable license to US Provisional Patent Application 
62/131,444, filed March 11, 2015, entitled, ``A method for developing 
malaria sporozoites in vitro'' to MalarVx, Inc., a for profit 
corporation, having a principal place of business at 307 Westlake 
Avenue North, Suite 200, Seattle, WA 98109.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Mr. Barry 
Datlof, Office of Research & Technology Assessment, (301) 619-0033. For 
patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808, 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to the grant of 
this license can file written objections along with supporting 
evidence, if any, within 15 days from the date of this publication. 
Written objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2015-29778 Filed 11-20-15; 8:45 am]
 BILLING CODE 3710-08-P